How David Lazar's Strategic Investment in OpGen Could Affect Your Portfolio. In a move that has caught the attention of investors and industry observers alike, David E. Lazar, a seasoned private investor known for his keen eye for value, has recently made a significant investment in OpGen, Inc. (Nasdaq: OPGN). On March 25, 2024, Lazar acquired a substantial stake in the company, purchasing 200,000 shares of Series E Preferred Stock...
$オプジェン(OPGN.US)$3/29/24 OpGen, Inc. has struck a deal with investor David E. Lazar, who will purchase 3 million shares of Series E Convertible Preferred Stock for $3 million. The initial payment of $200,000 has been made for 200,000 shares, with the rest to follow by May 1, 2024.
OpGen's New Dawn: David Lazar’s $3M Investment and Leadership Shift - What It Means for You. In an ambitious move that could significantly alter its trajectory, OpGen, Inc., a key player in the precision medicine industry based in Rockville, Maryland, has announced a strategic shift that puts private investor David Lazar at the helm as the new CEO. This development follows Lazar's substantial investment of $3 million in pr...
オプジェンに関するコメント
In a move that has caught the attention of investors and industry observers alike, David E. Lazar, a seasoned private investor known for his keen eye for value, has recently made a significant investment in OpGen, Inc. (Nasdaq: OPGN). On March 25, 2024, Lazar acquired a substantial stake in the company, purchasing 200,000 shares of Series E Preferred Stock...
In an ambitious move that could significantly alter its trajectory, OpGen, Inc., a key player in the precision medicine industry based in Rockville, Maryland, has announced a strategic shift that puts private investor David Lazar at the helm as the new CEO. This development follows Lazar's substantial investment of $3 million in pr...
📊⚡️📊
まだコメントはありません